Appia Bio
Closed
- Headquarters
- Los Angeles, California
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- appiabio.com
- Total Funding
- $52.0M
- Last Round
- $52.0M Series AMay 2021
About
Develops allogeneic CAR‑iNKT cell therapies from hematopoietic stem cells to treat cancers, partnering with industry for clinical development.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account